About CelluComp
CelluComp is a company based in Burntisland (United Kingdom) founded in 2006. CelluComp has raised $9.14 million across 2 funding rounds from investors including Scottish Enterprise, Sofinnova Partners and Scottish Investment Bank. The company has 6 employees. CelluComp offers products and services including Curran®. CelluComp operates in a competitive market with competitors including Acera Surgical, KLISBio, Bergen Carbon Solutions, ANF Technology and FibeRio Tech, among others.
- Headquarter Burntisland, United Kingdom
- Employees 6
- SectorsTechnologyChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website cellucomp.com
- Social LinkedIn X
- Legal Name Cellucomp Limited
- Date of Incorporation 04 Aug, 2004
- Jurisdiction EDINBURGH, SCOTLAND
- Annual Revenue$4.5 K (USD)61as on Jan 31, 2019
- Net Profit-$2.16 M (USD)-36as on Jan 31, 2019
- Total Equity Funding$9.14M (USD)
in 2 rounds
- Latest Funding Round$5.26M (USD), Series A
Mar 2016
- InvestorsScottish Enterprise
& 4 more
- Employee Count6
Products & Services of CelluComp
CelluComp offers a comprehensive portfolio of products and services, including Curran®.
Technology platform that enhances materials to replace plastics in packaging
Funding Insights of CelluComp
CelluComp has successfully raised a total of $9.14M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.26 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.14M
- Total Rounds 2
- Last Round Series A — $5.26M
- First Round $3.88M
(Nov 2013)
- Investors Count 5
All 2 funding rounds of CelluComp with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2016 | $5.26M | Series A | – | Scottish Investment Bank | |
| Nov 2013 | $3.88M | Seed | – | Sofinnova Partners |
5 investors in total: 5 institutional.
Investors in CelluComp
CelluComp has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Scottish Enterprise, Sofinnova Partners and Scottish Investment Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sofinnova Partners is focused on life sciences and healthcare investments. | – | sofinnovapartners.com | Paris, France | |
Company buyouts are targeted by this private equity firm. | – | claridgeinc.com | Montreal, Canada | |
- | – | discoveryinvestmentfund.co.uk | - | |
- | – | scottish-enterprise.com/sib | - | |
Business development and leadership training programs are offered to companies. | 1991 | scottish-enterprise.com | Glasgow, United Kingdom |
Investor details for CelluComp
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CelluComp
2 people are tracked at CelluComp (2 in leadership); the tracked headcount is 6.
| Name | Role | Group |
|---|---|---|
Christian Kemp-Griffin | CEO | Leadership |
Eric Whale | Director | Leadership |
Complete people profiles for CelluComp
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CelluComp
3 dated milestones of CelluComp across 10 years, from founding to its latest funding, stage changes and deals.
- Founded CelluComp is founded.
- Funding First funding round of $3.9M.
- Funding Latest funding round, Series A, of $5.3M.
Competitors of CelluComp
CelluComp operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acera Surgical, KLISBio, Bergen Carbon Solutions, ANF Technology and FibeRio Tech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| acera-surgical.com | 2013 | St. Louis, United States | $6.32M | – | Synthetic electrospun scaffolds are provided for regenerative medical uses. | |
| klis.bio | 2013 | Bresso, Italy | $8.58M | – | Developer of regenerative implantable products by using silk fibroins | |
| bergencarbonsolutions.com | 2016 | Bergen, Norway | – | 30 | Carbon nanofibers are produced from carbon dioxide via separation technology. | |
| anftechnology.com | 2010 | Tallinn, Estonia | $10M | – | Nano alumina fibers are produced as universal material enhancers. | |
| fiberiotech.com | 2009 | Mcallen, United States | $17.89M | – | Develops high-throughput nanofiber systems and materials for industrial applications. | |
| engain.co.kr | 2012 | Goyang, South Korea | – | – | Hydrogel and bio-gel for biological parameter measurement are supplied. | |
| dipolematerials.com | 2015 | Baltimore, United States | – | – | Developer of nano-fiber for tissue engineering, water filtration, & technical textiles | |
| nanostatics.com | 2005 | Circleville, United States | $11.13M | – | Specializes in nanofibers for high-performance materials. | |
| smartmembranes.de | 2009 | Halle, Germany | – | – | Porous materials using alumina and silicon are developed and manufactured. |
Detailed competitors of CelluComp
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellucomp
Complete news archive for CelluComp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to CelluComp
10 companies that operate in the same segment as CelluComp (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CelluComp
CelluComp was founded in 2006 and raised its 1st funding round 7 years after it was founded.
CelluComp is headquartered in Burntisland, United Kingdom. It is registered at Burntisland, Fife, United Kingdom.
CelluComp is a funded company, having raised a total of $9.14M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3.88M, raised on Nov 2013.
CelluComp has 6 employees.
Annual revenue of CelluComp is $4.5K as on Jan 31, 2019.
CelluComp was founded in 2006 in Burntisland, United Kingdom, focusing on materials science within the chemicals and manufacturing sectors. Nano-cellulose fibers are extracted from root vegetables to create Curran, a platelet-structured material characterized by lightness, strength, shear-thinning viscosity, suspension properties, and pH stability. This material is applied in paints, coatings, concrete, drilling fluids, cosmetics, personal care, and home care products.
CelluComp's top competitors include Acera Surgical, KLISBio and Bergen Carbon Solutions.
CelluComp offers Curran®.
CelluComp has 5 investors. Key investors include Scottish Enterprise, Sofinnova Partners, Scottish Investment Bank, Claridge Investment, and Discovery Investment Fund.
CelluComp operates through Cellucomp Limited.